Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Harmony Biosciences Holdings, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/11/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/11/2023 8-K Quarterly results
10/06/2023 SC 13G/A BlackRock Inc. reports a 10.2% stake in Harmony Biosciences Holdings, Inc.
10/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/04/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
09/27/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/24/2023 SC 13D Harmony Biosciences Holdings, Inc. reports a 13.1% stake in ZYNERBA PHARMACEUTICALS, INC.
08/14/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
08/14/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC."
08/14/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
07/27/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi...
05/31/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/31/2023 4/A Dayno Jeffrey M. (PRESIDENT, CEO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 125,000 options @ $0
05/30/2023 4 Dayno Jeffrey M. (PRESIDENT, CEO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 125,000 options @ $35.99, valued at $4.5M
05/26/2023 4 Nielsen Jack (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 5,224 options @ $35.99, valued at $188k
05/26/2023 4 Sender Gary (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 9,613 options @ $35.99, valued at $346k
05/26/2023 4 Graf R. Mark (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 5,224 options @ $35.99, valued at $188k
05/26/2023 4 Sabater Juan A. (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 5,224 options @ $35.99, valued at $188k
05/26/2023 4 Gracias Antonio J. (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 7,314 options @ $35.99, valued at $263.2k
05/26/2023 4 Szyper Linda M (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 5,224 options @ $35.99, valued at $188k
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/02/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/02/2023 8-K Quarterly results
04/24/2023 8-K Quarterly results
04/14/2023 ARS Form ARS - Annual Report to Security Holders:
04/14/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/31/2023 4 Kapadia Sandip (CFO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Paid exercise price by delivering 15,414 shares @ $33.36, valued at $514.2k
Exercised 30,000 restricted stock units @ $0
03/29/2023 8-K Quarterly results
03/10/2023 8-K Other Events  Interactive Data
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy